Mitigo Injection
Product Images NDC 66794-162

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Mitigo (NDC 66794-162). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Piramal Critical Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mitigo 1

FDA Label Image

Mitigo 10mg mL Carton

FDA Label Image

Mitigo 10mg mL Label

FDA Label Image

Mitigo 25mg mL Carton

FDA Label Image

Mitigo 25mg mL Label

This is a drug with NDC code 66794-162-02 and is only available via prescription. The drug should be protected from light and not frozen. The solution should not be used if it contains a precipitate that does not disappear when shaken. This drug contains Mumm-"e Sulfate 500mg/20mL (25 mg/0.1 mL). It should not be injected intravenously, intramuscularly or subcutaneously. It is to be used for continuous microinfusion devices via neuraxial administration only. It comes in a 20mL single-dose vial which is preservative-free. Contact 888-822-8431 for more information.*

FDA Label Image

Mitigo Structure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.